| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37b743dfc991c21233f2d5cfb5900b22 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-96494 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-531
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54346
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-531
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 |
| filingDate |
2021-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aff3b76f96b04ee5f66b99d8e4004af4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66a608b23378c0679b3ec226e66d17fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f0919f6df0fdc88800ee8964968a1fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54992d8ddc76c29d1d7d916428cf872a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9df0e16471132bcad7af6727bd2eeb2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37b9b8f75a16c2442f39d4c0947bf10c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4634a5aa32715722b5f1df2f2c4b654b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_617d6f6e90e7f90e49b6976bb14c4b03 |
| publicationDate |
2021-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-113281513-A |
| titleOfInvention |
MMP-3 kit, and preparation method and application thereof |
| abstract |
The invention belongs to the field of biology, and particularly relates to an MMP-3 kit, and a preparation method and application thereof. The MMP-3 kit includes reagent R1 and reagent R2; the preparation method of the latex particles of the anti-human MMP-3 antibody in the reagent R2 comprises the following steps: s1: activating latex microsphere particles; s2: adding anti-human MMP-3 antibody to combine with the activated latex particles; s3: blocking the latex particles combined with the antibody to obtain a latex system; s4: replacing the latex system with a tangential flow system; s5: the latex particles that produced aggregation after the liquid change were dispersed using a homogenizer. The invention provides a preparation method of tangential flow filtration and homogenizer dispersion, which is used for replacing a centrifugal machine and an ultrasonic instrument and can save operation time and equipment cost. |
| priorityDate |
2021-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |